These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28222044)

  • 1. Endocrine system on chip for a diabetes treatment model.
    Nguyen DT; van Noort D; Jeong IK; Park S
    Biofabrication; 2017 Feb; 9(1):015021. PubMed ID: 28222044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-culture of clonal beta cells with GLP-1 and glucagon-secreting cell line impacts on beta cell insulin secretion, proliferation and susceptibility to cytotoxins.
    Green AD; Vasu S; Moffett RC; Flatt PR
    Biochimie; 2016 Jun; 125():119-25. PubMed ID: 27015674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costus pictus D. Don leaf extract stimulates GLP-1 secretion from GLUTag L-cells and has cytoprotective effects in BRIN-BD11 β-cells.
    Patibandla C; Khan ZI; MacGregor L; Campbell MJ; Patterson S
    J Ethnopharmacol; 2020 Oct; 260():112970. PubMed ID: 32422353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine-Elicited Secretion of Glucagon-Like Peptide 1 Is Governed by an Activated Glutamate Dehydrogenase.
    Andersson LE; Shcherbina L; Al-Majdoub M; Vishnu N; Arroyo CB; Aste Carrara J; Wollheim CB; Fex M; Mulder H; Wierup N; Spégel P
    Diabetes; 2018 Mar; 67(3):372-384. PubMed ID: 29229616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity.
    Vasu S; Moffett RC; McClenaghan NH; Flatt PR
    Exp Cell Res; 2015 Aug; 336(1):100-8. PubMed ID: 26027945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1).
    Wideman RD; Yu IL; Webber TD; Verchere CB; Johnson JD; Cheung AT; Kieffer TJ
    Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13468-73. PubMed ID: 16938896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP-secretion coupling is impaired in diabetic GK/Par rat β-cells: a defect counteracted by GLP-1.
    Dolz M; Movassat J; Bailbé D; Le Stunff H; Giroix MH; Fradet M; Kergoat M; Portha B
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E797-806. PubMed ID: 21750265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells.
    Shang J; Li J; Keller MP; Hohmeier HE; Wang Y; Feng Y; Zhou HH; Shen X; Rabaglia M; Soni M; Attie AD; Newgard CB; Thornberry NA; Howard AD; Zhou YP
    Mol Endocrinol; 2015 Sep; 29(9):1243-53. PubMed ID: 26218441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
    Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
    Yabe D; Seino Y
    Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human EndoC-βH1 β-cells form pseudoislets with improved glucose sensitivity and enhanced GLP-1 signaling in the presence of islet-derived endothelial cells.
    Spelios MG; Afinowicz LA; Tipon RC; Akirav EM
    Am J Physiol Endocrinol Metab; 2018 May; 314(5):E512-E521. PubMed ID: 29351476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD; Gault VA; O'Harte FP; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1.
    Liu MJ; Shin S; Li N; Shigihara T; Lee YS; Yoon JW; Jun HS
    Mol Ther; 2007 Jan; 15(1):86-93. PubMed ID: 17164779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
    Ma X; Guan Y; Hua X
    J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice.
    Pais R; Zietek T; Hauner H; Daniel H; Skurk T
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G330-7. PubMed ID: 24875103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells.
    Kuhre RE; Wewer Albrechtsen NJ; Deacon CF; Balk-Møller E; Rehfeld JF; Reimann F; Gribble FM; Holst JJ
    J Mol Endocrinol; 2016 Apr; 56(3):201-11. PubMed ID: 26819328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human embryonic stem cell differentiation into insulin secreting β-cells for diabetes.
    Bose B; Shenoy SP; Konda S; Wangikar P
    Cell Biol Int; 2012 Nov; 36(11):1013-20. PubMed ID: 22897387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis.
    Traub S; Meier DT; Schulze F; Dror E; Nordmann TM; Goetz N; Koch N; Dalmas E; Stawiski M; Makshana V; Thorel F; Herrera PL; Böni-Schnetzler M; Donath MY
    Cell Rep; 2017 Mar; 18(13):3192-3203. PubMed ID: 28355570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.